Dr. William M. Dugan Jr., M.D.

Expert Publications

• Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program.
• Clinical Oncology Program: a community cancer control model.
• Clinical Oncology Program: a community cancer control model.
• An attempt to employ the Zung Self-Rating Depression Scale as a "lab test" to trigger follow-up in ambulatory oncology clinics: criterion validity and detection.
• Access to communication technologies in a sample of cancer patients: an urban and rural survey.
• Clinical alternatives to radical mastectomy.
• Clinical alternatives to radical mastectomy.
• Back pain: the primrose path--a case report.
• Cancer corner.
• Continuous infusion metoclopramide: clinical trials, pharmacokinetic considerations and cost-effectiveness.
• Reliability of videotape technology in assessing the efficacy of anti-emetic drugs.
• The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology.
• Oncology waste management.
• Comment: revised treatment of ulcerative stomatitis.
• Colorectal cancer: screening, detection.

Media Releases

Get to know Hematologist-Oncologist Dr. William M. Dugan Jr., who serves patients throughout the State of Indiana.

A hematologist-oncologist, Dr. Dugan Jr. is a cancer specialist trained in blood disorders and the medical treatment of malignancies.

In the state of Indiana, he is affiliated with Columbus Regional Hospital, Community Hospital East, Community Hospital North, Woodlawn Hospital, Margaret Mary Health, Indiana University Health University Hospital, and Parkview Wabash Hospital.

“I’ve been a practicing medical oncologist for over 36 years, and the most gratifying work I have done is what I do in the rural hospital setting every week. Hardly a day goes by that a patient doesn’t thank me for not having to drive long distances to receive cancer care” expressed the doctor. 

Graduating with the class of 1963 at the Indiana University School of Medicine, Dr. Dugan Jr. went on to further his studies. He performed his internship, residency in internal medicine, and fellowship in hematology and medical oncology at the said establishment in 1964, 1967, and 1968, respectively. 

A provider of educational programs to patients, families, physicians and nurses, he served as the co-founder and president of Community Cancer Care in Indianapolis, an assistant clinical professor at the Indiana University School of Medicine, and as the co-founder of the Quality of Life Foundation.

An active cancer researcher, Dr. Dugan Jr. is board-certified in medical oncology and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Obtaining membership status, he is an active member of the American Society of Clinical Oncology.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Recognized for his work, Dr. Dugan Jr. is the 2005 recipient of the Rural Health Practitioner of the Year Award. National Rural Health Association’s 28th Annual Conference in New Orleans, the award recognizes the rural health leader whose dedication and commitment exemplifies the highest standards of rural health care and service. 

Dr. Dugan was honored for his outstanding contributions made to health care in rural areas for over 23 years, and is the first specialist to win the award.

Recommended Articles

• John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

  Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

• How to Show Social Support for Lymphoma

  A cancer diagnosis can shake an individual’s world, and not just the physical aspects of their world, but all corners of it. Although cancer attacks the body, it necessarily also affects a person’s mental and emotional state, and it can have an impact on other people close to the affected...

• How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma

  Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...

• Facts About Multiple Myeloma

  Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...

• Multiple Myeloma: What is Autotransplantation?

  During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...

• Tips on How to Live with Multiple Myeloma

  Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...